Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Inclusion Criteria: * Stage II - III Non Small Cell Lung Cancer Exclusion Criteria: * Primary tumor directly invading into any mediastinal structures, such as the heart, major blood vessels, esophagus, trachea, and the proximal bronchial tree. * Prior chemotherapy for NSCLC * Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields. * Severe, active co-morbidity * Pregnancy or women of childbearing potential * Any history of allergic reaction to paclitaxel or other taxanes, or to carboplatin * Uncontrolled neuropathy ≥ grade 2.